Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [2]
- ELISA [1]
- Immunoprecipitation [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN395050 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-IMP (Inosine 5'-Monophosphate) Dehydrogenase 2 (IMPDH2) (AA 1-515) antibody
- Antibody type
- Monoclonal
- Description
- This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 1-515
- Isotype
- IgG
- Antibody clone number
- 1E12-B6
- Vial size
- 100 μg
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Submitted references Polymorphisms in type I and II inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetil.
Genetic polymorphisms influence mycophenolate mofetil-related adverse events in pediatric heart transplant patients.
An inosine 5'-monophosphate dehydrogenase 2 single-nucleotide polymorphism impairs the effect of mycophenolic acid.
Genetic variations in the HGPRT, ITPA, IMPDH1, IMPDH2, and GMPS genes in Japanese individuals.
IMPDH2 genetic polymorphism: a promoter single-nucleotide polymorphism disrupts a cyclic adenosine monophosphate responsive element.
Gensburger O, Van Schaik RH, Picard N, Le Meur Y, Rousseau A, Woillard JB, Van Gelder T, Marquet P
Pharmacogenetics and genomics 2010 Sep;20(9):537-43
Pharmacogenetics and genomics 2010 Sep;20(9):537-43
Genetic polymorphisms influence mycophenolate mofetil-related adverse events in pediatric heart transplant patients.
Ohmann EL, Burckart GJ, Brooks MM, Chen Y, Pravica V, Girnita DM, Zeevi A, Webber SA
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2010 May;29(5):509-16
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2010 May;29(5):509-16
An inosine 5'-monophosphate dehydrogenase 2 single-nucleotide polymorphism impairs the effect of mycophenolic acid.
Winnicki W, Weigel G, Sunder-Plassmann G, Bajari T, Winter B, Herkner H, Sengoelge G
The pharmacogenomics journal 2010 Feb;10(1):70-6
The pharmacogenomics journal 2010 Feb;10(1):70-6
Genetic variations in the HGPRT, ITPA, IMPDH1, IMPDH2, and GMPS genes in Japanese individuals.
Kudo M, Saito Y, Sasaki T, Akasaki H, Yamaguchi Y, Uehara M, Fujikawa K, Ishikawa M, Hirasawa N, Hiratsuka M
Drug metabolism and pharmacokinetics 2009;24(6):557-64
Drug metabolism and pharmacokinetics 2009;24(6):557-64
IMPDH2 genetic polymorphism: a promoter single-nucleotide polymorphism disrupts a cyclic adenosine monophosphate responsive element.
Garat A, Cauffiez C, Hamdan-Khalil R, Glowacki F, Devos A, Leclerc J, Lionet A, Allorge D, Lo-Guidice JM, Broly F
Genetic testing and molecular biomarkers 2009 Dec;13(6):841-7
Genetic testing and molecular biomarkers 2009 Dec;13(6):841-7
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- ELISA
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IP